Cogent Biosciences, Inc. (COGT)
37.63
-0.32
(-0.84%)
USD |
NASDAQ |
Feb 10, 10:43
Cogent Biosciences EPS Diluted (Quarterly) : -0.5884 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Cidara Therapeutics, Inc. | -3.096 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.93M |
| Total Expenses (Quarterly) | 80.93M |
| Enterprise Value | 5.603B |
| Earnings Yield | -6.30% |
| Normalized Earnings Yield | -6.300 |